| pubmed-article:10484947 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10484947 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:10484947 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:10484947 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10484947 | pubmed:dateCreated | 1999-9-27 | lld:pubmed |
| pubmed-article:10484947 | pubmed:abstractText | The purpose of this study was to evaluate the clinical safety and efficacy of risperidone compared to haloperidol in patients with treatment-refractory schizophrenia. | lld:pubmed |
| pubmed-article:10484947 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10484947 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10484947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10484947 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10484947 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10484947 | pubmed:issn | 0002-953X | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:MintzJJ | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:MarderS RSR | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:GreenM FMF | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:MarshallB... | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:WirshingW CWC | lld:pubmed |
| pubmed-article:10484947 | pubmed:author | pubmed-author:WirshingD ADA | lld:pubmed |
| pubmed-article:10484947 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10484947 | pubmed:volume | 156 | lld:pubmed |
| pubmed-article:10484947 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10484947 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10484947 | pubmed:pagination | 1374-9 | lld:pubmed |
| pubmed-article:10484947 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:meshHeading | pubmed-meshheading:10484947... | lld:pubmed |
| pubmed-article:10484947 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10484947 | pubmed:articleTitle | Risperidone in treatment-refractory schizophrenia. | lld:pubmed |
| pubmed-article:10484947 | pubmed:affiliation | Department of Psychiatry, VA Greater Los Angeles Healthcare System, CA 90073, USA. | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10484947 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10484947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10484947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10484947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10484947 | lld:pubmed |
